Form 4: 10x Genomics Executive Benjamin J. Hindson Sells Shares to Cover Tax Obligations

Benjamin J. Hindson, President and Chief Scientific Officer of 10x Genomics, sold 4,351 shares of Class A Common Stock on August 22, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On August 22, 2024, Benjamin J. Hindson, President and Chief Scientific Officer of 10x Genomics, sold 4,351 shares of Class A Common Stock.
• The sale was executed at a price of $22.5297 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Hindson directly owns 345,704 shares of 10x Genomics Class A Common Stock.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a routine transaction related to executive compensation and doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

This is a routine Form 4 filing, indicating insider activity related to stock compensation. It's common for executives to sell shares to cover tax obligations when restricted stock units vest.

Stakeholder Impact

• The sale could have a minor, temporary impact on the stock price due to the increased selling pressure, but it's unlikely to be significant given the relatively small number of shares involved.

Key Dates